Safety of and Immune Response to the Experimental Preventive HIV Vaccine, EP HIV-1090, in Healthy, HIV-1 Uninfected Adults

NCT00141024 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

84

Enrollment

NIH

Sponsor class

Conditions

HIV Infections

Interventions

BIOLOGICAL: EP HIV-1043
BIOLOGICAL: EP HIV-1090

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)